Skip to main content

Table 1 Progression of kidney and angiomyolipoma volume along time. Laboratory test while on and off mTOR inhibitor treatment

From: Insight into response to mTOR inhibition when PKD1 and TSC2 are mutated

  1. Shaded columns represent the period in which the patient received mTOR inhibitors